Here are relevant reports on : ultrasound-market
-
Ultrasound Needle Guides Market by Type (Reusable, Disposable), Application (Tissue Biopsy, Fluid Aspiration, Nerve Block, Regional Anesthesia, Vascular Access), End User (Hospitals, Clinics, ASC, Diagnostic Imaging Centers) & Region - Global Forecasts to 2027
The global ultrasound needle guides market, stood at US$274 million in 2022 and is projected to advance at a resilient CAGR of 6.1% from 2022 to 2028, culminating in a forecasted valuation of US$369 billion by the end of the period. Ultrasound needle guides have applications in the diagnosis and treatment of diseases such as cancer and CVD. The prevalence of these target diseases is increasing across the globe due to factors such as the rising geriatric population and the increasing adoption of sedentary lifestyles.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Ultrasound Probe Covers Market by Type (Disposable, Reusable), Material (Latex, Latex-free), Application (Endocavitary), End User (Hospitals, Diagnostic Imaging Centers, Maternity Centers, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global ultrasound probe covers market in terms of revenue was estimated to be worth $213 million in 2022 and is poised to reach $283 million in 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021
The global diagnostic catheters market is projected to grow at a CAGR of around 7.3%. The diagnostic catheters market comprises a network of players involved in the research and product development; raw material supply; medical device manufacturing; distribution and sale; and post-sales services. The major players in the global market are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc. (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (The Netherlands), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), C. R. Bard, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Non Invasive Prenatal Testing Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs) - Global Forecasts to 2029
The global non invasive prenatal testing market, valued at US$6.4 billion in 2023, stood at US$7.2 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$14.1 billion by the end of the period. The primary growth factors propelling this market include spiking investments, incentives, and support from both state governments and private companies, which are driving access to and demand for NIPT technologies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
US Medical Simulation Market by offering (Anatomical Models [Patient {High Fidelity}, Surgical {Laparoscopic, Ortho, Gynec, Spine}, Trainers, Ultrasound], Software), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The US Medical Simulation market, valued at USD 1.20 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The US medical simulation market continues to expand, supported by rising demand for advanced clinical training, stricter regulatory and accreditation requirements, and a growing healthcare workforce.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Non-Thermal Processing Market for Food by Technology (HPP, PEF, Irradiation, Ultrasound, Cold Plasma), Food Type (Meat, Beverages), Function (Microbial Inactivation, Quality Assurance), and Region - Global Forecast to 2022
The global market for non-thermal processing market has grown exponentially in the last few years. The market is estimated to be valued at USD 818.6 Million in 2017, and is projected to reach USD 1,224.2 Million by 2022, at a CAGR of around 8.4% from 2017. Emerging economies such as India, China, and Brazil are the potential primary markets of the industry. Growing trend of novel technologies and process optimizaiton are driving the market for non-thermal processing. This report includes a study of business strategies, along with the product portfolios of leading companies. More than 160 developments were tracked for the 15 companies in the non-thermal processing market. It includes the profiles of leading companies such as Bosch (Germany), Bühler (Switzerland), Hiperbaric España (Spain), Nordion (Canada), Avure Technologies (US), Emerson (US), CHIC FresherTech (US), Elea Technology (Germany), Pulsemaster (Netherlands), Gray*Star (US), Dukane (US), and Symbios Technologies (US).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Cardiac Ablation Market by Technology (Radiofrequency, Electrical, Cryoablation, Ultrasound, Microwave), Product (Irreversible Electroporation, HIFU, MRgFUS), Application (Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery) - Global Forecast to 2019
The global cardiac ablation market is poised to grow at a CAGR of 12.5% during 2014-2019, and is expected to reach a value of ~$883.1 Million in 2019. A number of factors such as growing geriatric population coupled with increasing population base of cardiovascular disease patients, technological advancements in the field of ablation devices, and growing awareness about benefits of cardiac ablation procedures over conventional therapeutic and surgical procedures are fuelling the growth of the global cardiac ablation market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Europe Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology, Urology), Route of Administration (IV, Oral), End User - Forecast to 2031
The Europe contrast media market is projected to reach USD 3.19 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
